Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Françoise Porrot

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
Medrxiv : the Preprint Server for Health Sciences|July 3, 2023
Antiviral activities of sotrovimab against BQ.1.1 and XBB.1.5 in sera of treated patientsTimothée Bruel, Lou-Léna Vrignaud, Françoise Porrot, et al.
Med (New York, N.Y.)|October 14, 2023
Sotrovimab therapy elicits antiviral activities against Omicron BQ.1.1 and XBB.1.5 in sera of immunocompromised patientsTimothée Bruel, Lou-Léna Vrignaud, Françoise Porrot, et al.
Cell|August 27, 2025
Structural basis of poxvirus fusion regulation and anti-A16/G9 antibody-mediated neutralization and protectionAnnalisa Meola, Riccardo Vernuccio, Leandro Battini, et al.
Science Translational Medicine|December 10, 2025
Antigen-agnostic identification of poxvirus broadly neutralizing antibodies targeting OPG153Ida Paciello, Emily J Rundlet, Ling Zhou, et al.
Nature|July 8, 2021
Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralizationDelphine Planas, David Veyer, Artem Baidaliuk, et al.
Nature|January 11, 2022
Considerable escape of SARS-CoV-2 Omicron to antibody neutralizationDelphine Planas, Nell Saunders, Piet Maes, et al.
The Journal of Experimental Medicine|March 24, 2026
DNA-PK interacts with cyclic dinucleotides and inhibits type I interferon responsesIsabelle K Vila, Yasmine Messaoud-Nacer, Clara Taffoni, et al.
Cell Host & Microbe|May 17, 2023
Complement-dependent mpox-virus-neutralizing antibodies in infected and vaccinated individualsMathieu Hubert, Florence Guivel-Benhassine, Timothée Bruel, et al.
Nature Medicine|March 27, 2021
Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodiesDelphine Planas, Timothée Bruel, Ludivine Grzelak, et al.
Science Translational Medicine|August 21, 2020
A comparison of four serological assays for detecting anti-SARS-CoV-2 antibodies in human serum samples from different populationsLudivine Grzelak, Sarah Temmam, Cyril Planchais, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Medrxiv : the Preprint Server for Health Sciences|July 3, 2023
Antiviral activities of sotrovimab against BQ.1.1 and XBB.1.5 in sera of treated patientsTimothée Bruel, Lou-Léna Vrignaud, Françoise Porrot, et al.
Med (New York, N.Y.)|October 14, 2023
Sotrovimab therapy elicits antiviral activities against Omicron BQ.1.1 and XBB.1.5 in sera of immunocompromised patientsTimothée Bruel, Lou-Léna Vrignaud, Françoise Porrot, et al.
Cell|August 27, 2025
Structural basis of poxvirus fusion regulation and anti-A16/G9 antibody-mediated neutralization and protectionAnnalisa Meola, Riccardo Vernuccio, Leandro Battini, et al.
Science Translational Medicine|December 10, 2025
Antigen-agnostic identification of poxvirus broadly neutralizing antibodies targeting OPG153Ida Paciello, Emily J Rundlet, Ling Zhou, et al.
Nature|July 8, 2021
Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralizationDelphine Planas, David Veyer, Artem Baidaliuk, et al.
Nature|January 11, 2022
Considerable escape of SARS-CoV-2 Omicron to antibody neutralizationDelphine Planas, Nell Saunders, Piet Maes, et al.
The Journal of Experimental Medicine|March 24, 2026
DNA-PK interacts with cyclic dinucleotides and inhibits type I interferon responsesIsabelle K Vila, Yasmine Messaoud-Nacer, Clara Taffoni, et al.
Cell Host & Microbe|May 17, 2023
Complement-dependent mpox-virus-neutralizing antibodies in infected and vaccinated individualsMathieu Hubert, Florence Guivel-Benhassine, Timothée Bruel, et al.
Nature Medicine|March 27, 2021
Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodiesDelphine Planas, Timothée Bruel, Ludivine Grzelak, et al.
Science Translational Medicine|August 21, 2020
A comparison of four serological assays for detecting anti-SARS-CoV-2 antibodies in human serum samples from different populationsLudivine Grzelak, Sarah Temmam, Cyril Planchais, et al.
Pageof 6